The Healthcare Standard

Mental Health App Developed to Reduce Young People Self-Harming

A smartphone app has been designed to manage negative emotions and periods of anxiety in order to reduce self-harm in young people, new data has revealed.

Clinical psychologist Professor Paul Stallard, of the University of Bath, developed the app in conjunction with patient groups.

A number of papers published in the Journal of Medical Internet Research emphasize that the app could help tackle self-harm in young people.

Head of psychological therapies for Oxford Health NHS Foundation Trust, Prof Stallard, claims the idea for BlueIce came about as a result of his work with child and adolescent mental health services (CAMHS).

“Many of the young people I was working with were self-harming but nearly all had their mobile phone close by,” he said.

Read more…

The Healthcare Standard

Global Myocardial Infarction Drug Market Outlook 2019-2025: BioCardia, Inc., Biscayne Pharmaceuticals, Inc.

The strike of the global Myocardial Infarction Drug market is mentioned in the part of those areas, It demonstrates various segments JVS-200, KR-33028, AMRS-001, ANG-4011, Balixafortide, CAP-1002, Cenderitide, Others and sub-segments Research Center, Hospital, Clinic of the global Myocardial Infarction Drug market.

The Myocardial Infarction Drug market report gives the certified progression segments and separate regions that strikingly sway the market improvement outline out information about the various conditions of the Myocardial Infarction Drug market altogether. The Myocardial Infarction Drug market report moreover combines an assessed effect of government’s models and plans over the market. The Myocardial Infarction Drug market report involves different demonstrative systems, for instance, SWOT examination to get the data with respect to the foreseen monetary vulnerabilities identified with the flow of the market, which relies upon the current information.

The general Myocardial Infarction Drug market report offers cutting edge perspectives on the major and moreover minor aspects that may impact up or fasten the market headway. The Myocardial Infarction Drug market report gives examination information that can change the commanding parts in the market and will additionally give a geographical division of the general market on a wide-ranging estimation. The Myocardial Infarction Drug report gives in-detail information to comprehend the basic market parts that guide with settling on business choices dependent on invention, request, and organizations of the thing as exhibited by the examination of the market. The Myocardial Infarction Drug market report gives gauge information of inevitable years dependent on the estimated structure of the market. The Myocardial Infarction Drug market report outfits graphical information with figures and pictures for elucidation.

Read more…


The Healthcare Standard

Why Getting Medical Advice Before Traveling is Vital to Having a Safe Trip

If you’re planning a trip overseas, you’re probably thinking about what you’re going to pack, the places you’ll visit, and the food you’re going to eat – but are you thinking about your health?

Experts say getting medical advice before you take off is just as important as making an itinerary.

“There are illnesses associated with developing countries, tropical countries.”

Doctor Keith Armitage, medical director of University Hospital’s Roe Green Center for Travel Medicine says most people get sick while traveling from mosquitoes, food, and water, but if you take precautions there’s no need to worry.

“We recommend people come two or three weeks before they travel, some of the vaccines take time to take effect. So if people come the day before they travel, we can still help them. But in general, two or three weeks,” Armitage said.

The most common vaccine given at the Roe Green Center is Hepatitis A, which is very common in developing countries along with typhoid fever.

Doctor Armitage says people who grew up in the United States lack immunity to those viruses, and for those heading to Europe this summer there’s a new warning.

“There’s a lot of measles in western Europe. People born between 1957 and around 1980 may not have immunity to measles. The vaccines that were given in the late 50s and 60s and early 70s don’t provide prolonged protection,” Armitage said.

Read more…

The Healthcare Standard

Dignity Health Nurses Protest Over Patient Safety, Staffing Concerns

Dignity Health nurses in Southern California have launched a series of protests about what they say are unsafe conditions at three facilities, according to the union that represents them.

Protesting took place July 31 at St. John’s Regional Medical Center in Oxnard, Calif. It is scheduled to continue Aug. 1 at Northridge (Calif.) Hospital Medical Center and Aug. 6 at St. John’s Pleasant Valley Hospital in Camarillo, Calif.

Nurses have expressed concerns about patient safety and the safety of their colleagues because of inadequate staffing and security, Service Employees International Union Local 121RN said in a news release.

“Nurses have suffered injuries in preventable patient attacks,” union leaders wrote. Nurses “also report regularly working 12-hour shifts without breaks because of inadequate staffing.”

In response to the protesting, Dignity Health told Becker’s: “Throughout these negotiations we have shown respect for our employees and we will continue to bargain in good faith. We pledge to maintain open lines of communication and do everything we can to reach an agreement that is fair to our employees, our patients and our hospital.”


Read more…

The Healthcare Standard

Why Health Companies are Branding Themselves as Tech Companies

From digital health startups to primary care groups, companies are increasingly branding themselves2 as tech companies first, health care companies second. Shunning ties to the mission-driven health care sector may seem counterintuitive at best and sacrilegious at worst.

Yet for many new entrants, such an approach — which we call avoidant positioning — is becoming the norm. We unpack three weaknesses of the health care label that may be fueling a broader identity crisis for these firms, and suggest that this trend represents a wake-up call for health care.

Health care, by virtue of its biomedical underpinnings, gives great credence to following the scientific method before embracing new initiatives. Physicians are often skeptical of new interventions without convincing evidence. The rigorous process of evaluating a new pharmaceutical product or the complex methodology of a randomized clinical trial, however, often cannot be applied to a delivery-side intervention like a new care model. Innovations in health care delivery are better evaluated through multiple small-scale, iterative pilots that let stakeholders validate hypotheses before moving into a scaled model.

To the extent that physicians are starting to appreciate the benefits3 of a piloted approach, there is still a certain inertia4 in spreading the lessons of a successful program across an enterprise. There are many reasons for this, including cultural resistance, financial short-sightedness, organizational complexity, and risk-averse leadership.

Read more…